CI invests directly in other Connecticut-based venture capital funds investing in technology and biosciences. This strategy gives us an efficient way to diversify, to access other funds, and to work with partners who have deep knowledge of emerging technology companies with high potential.
Bloomberg identifies Connecticut as one of the most innovative states. Read article.
CI is number two in Pitchbook’s report on the top angel and seed investors in healthtech. View report.
In Q1, CI was the most active venture capital investor in New England and the seventh most active VC in the nation. View PitchBook report.